Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary: The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study

Author： Paragh György  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.9, 2007-01, pp. : 647-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study

By Alemao Evo  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 349-355

Adis International

Access to resources Recommend Favorite

New lipid-modifying therapies

By Bruckert Eric  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 325-335

Informa Healthcare

Access to resources Recommend Favorite

Cholesterol and plasma lipid modifying patents

By Suckling K.E.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. : 1415-1423

Informa Healthcare

Access to resources Recommend Favorite

Lipid Management and Cholesterol Goal Attainment in Norway

By Ose Leiv  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 121-128

Adis International

Access to resources Recommend Favorite

Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

By Salam Amar  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 387-389

Springer Publishing Company

Access to resources Recommend Favorite